ARSS.F Stock Overview
Assura plc is a national healthcare premises specialist and UK REIT based in Altrincham, UK - caring for more than 600 primary healthcare buildings, from which over six million patients are served.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 3/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 5/6 |
Assura Plc Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | UK£0.52 |
52 Week High | UK£0.68 |
52 Week Low | UK£0.48 |
Beta | 0.30 |
1 Month Change | 8.16% |
3 Month Change | n/a |
1 Year Change | n/a |
3 Year Change | -51.48% |
5 Year Change | n/a |
Change since IPO | -32.88% |
Recent News & Updates
Recent updates
Shareholder Returns
ARSS.F | US Health Care REITs | US Market | |
---|---|---|---|
7D | 0% | 1.9% | 1.6% |
1Y | n/a | 8.3% | 26.2% |
Return vs Industry: Insufficient data to determine how ARSS.F performed against the US Health Care REITs industry.
Return vs Market: Insufficient data to determine how ARSS.F performed against the US Market.
Price Volatility
ARSS.F volatility | |
---|---|
ARSS.F Average Weekly Movement | n/a |
Health Care REITs Industry Average Movement | 3.7% |
Market Average Movement | 6.1% |
10% most volatile stocks in US Market | 16.6% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: ARSS.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine ARSS.F's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2003 | 86 | Jonathan Murphy | www.assuraplc.com |
Assura plc is a national healthcare premises specialist and UK REIT based in Altrincham, UK - caring for more than 600 primary healthcare buildings, from which over six million patients are served. A constituent of the FTSE 250 and the EPRA indices, as at 30 September 2023, Assura's portfolio was valued at £2.7 billion. At Assura, we BUILD for health.
Assura Plc Fundamentals Summary
ARSS.F fundamental statistics | |
---|---|
Market cap | US$1.58b |
Earnings (TTM) | -US$210.34m |
Revenue (TTM) | US$191.17m |
8.3x
P/S Ratio-7.5x
P/E RatioIs ARSS.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ARSS.F income statement (TTM) | |
---|---|
Revenue | UK£152.60m |
Cost of Revenue | UK£13.80m |
Gross Profit | UK£138.80m |
Other Expenses | UK£306.70m |
Earnings | -UK£167.90m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
May 21, 2024
Earnings per share (EPS) | -0.056 |
Gross Margin | 90.96% |
Net Profit Margin | -110.03% |
Debt/Equity Ratio | 81.8% |
How did ARSS.F perform over the long term?
See historical performance and comparison